Author details

Full Name

Bettina Meiser

Affiliation

ORCID

Career Start Year

1999

Papers

227

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37012465	Exploring the impact of the reclassification of a hereditary cancer syndrome gene variant: emerging themes from a qualitative study.	J Community Genet	2023
35913122	Impact of BRCA1/2 cascade testing on anxiety, depression, and cancer worry levels among unaffected relatives in a multiethnic Asian cohort.	Journal of Genetic Counseling	2023
37088634	Health professionals' role in the transfer of mosaic embryos after preimplantation genetic testing for aneuploidies.		2023
37210765	Family communication and results disclosure after germline sequencing: A mixed methods study.	Patient Educ Couns	2023
36763037	Population-based testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.		2023
35153126	Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients.	Patient Educ Couns	2022
35839313	What is the effect of a low literacy talking book on patient knowledge, anxiety and communication before radiation therapy starts? A pilot study.	Journal of Medical Radiation Sciences	2022
35577937	Perceptions of causal attribution and attitudes to genetic testing among people with schizophrenia and their first-degree relatives.	Eur J Hum Genet	2022
36157005	Exploration of decision-making regarding the transfer of mosaic embryos following preimplantation genetic testing: a qualitative study.		2022
36006036	Factors influencing patients' decision-making about preimplantation genetic testing for monogenic disorders.	Human Reproduction	2022
35487418	Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.	Eur J Med Genet	2022
35931093	Concerns about the use of polygenic embryo screening for psychiatric and cognitive traits.	Lancet Psychiatry	2022
36195055	Which Test Is Best? A Cluster-Randomized Controlled Trial of a Risk Calculator and Recommendations on Colorectal Cancer Screening Behaviour in General Practice.	Public Health Genomics	2022
35604703	Psychological outcomes in advanced cancer patients after receiving genomic tumor profiling results.	Health Psychol	2022
36618023	The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet.	Adv Genet (Hoboken)	2022
34016496	Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients.	Patient Educ Couns	2022
33970363	Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.	Familial Cancer	2022
34223688	Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk.	Journal of Genetic Counseling	2022
34218500	Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.	J Genet Couns	2022
35277654	Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.	Eur J Hum Genet	2022
34727336	Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.	J Community Genet	2022
35183447	Decisional needs of patients considering preimplantation genetic testing: a systematic review.	Reproductive BioMedicine Online	2022
34713948	The impact of Marfan syndrome on an Aboriginal Australian family: 'I don't like it as much as I don't like cancer'.	Journal of Genetic Counseling	2022
34755933	Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.	Am J Med Genet A	2022
34676049	The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey.	Oncotarget	2021
34240516	Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling.	Psychooncology	2021
33706980	Communicating polygenic risk scores in the familial breast cancer clinic.	Patient Education and Counseling	2021
34172541	Evaluation of two population screening programmes for founder mutations in the Australian Jewish community: a protocol paper.	BMJ Open	2021
33583580	What happens after menopause? (WHAM): A prospective controlled study of depression and anxiety up to 12Â months after premenopausal risk-reducing bilateral salpingo-oophorectomy.	Gynecol Oncol	2021
33956303	Oncologists' perspectives of telephone genetic counseling to facilitate germline BRCA1/2 testing for their patients with high-grade serous ovarian cancer.	Journal of Community Genetics	2021
33739311	A prospective controlled study of sexual function and sexually related personal distress up to 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy.	Menopause	2021
33470033	Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'.	J Genet Couns	2021
34216141	Knowledge, views and expectations for cancer polygenic risk testing in clinical practice: A cross-sectional survey of health professionals.	Clin Genet	2021
33836815	Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.	Hered Cancer Clin Pract	2021
33663518	Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres.	Implementation Science	2021
34036439	Fear of cancer recurrence in patients undergoing germline genome sequencing.	Support Care Cancer	2021
34341522	Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.	Genet Med	2021
33245177	Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting.	Journal of Genetic Counseling	2021
33129629	Family communication about genomic sequencing: A qualitative study with cancer patients and relatives.	Patient Educ Couns	2021
32544291	Advanced cancer patient preferences for receiving molecular profiling results.	Psychooncology	2020
32369270	Psychosocial implications of living with familial risk of a psychiatric disorder and attitudes to psychiatric genetic testing: A systematic review of the literature.	Am J Med Genet B Neuropsychiatr Genet	2020
32066492	Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field.	Breast Cancer Research	2020
32407502	Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer.	JAMA Netw Open	2020
31833054	Uptake of polygenic risk information among women at increased risk of breast cancer.	Clinical Genetics	2020
32090758	Exploration of experiences with and understanding of polygenic risk scores for bipolar disorder.	J Affect Disord	2020
31980566	Cancer patients' views and understanding of genome sequencing: a qualitative study.	J Med Genet	2020
32457804	Causal Attributions in an Australian Aboriginal Family With Marfan Syndrome: A Qualitative Study.	Frontiers in Genetics	2020
32450551	Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling.	Transl Oncol	2020
31358263	The relationship between psychosocial factors and biomarkers in cancer patients: A systematic review of the literature.	European Journal of Oncology Nursing	2019
30206354	Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review.	European Journal of Human Genetics	2019